

FEAR & GREED | Business News
Fear and Greed
Business news you can use. A daily business news podcast with journalists Sean Aylmer and Michael Thompson. Find out more at https://fearandgreed.com.au
Episodes
Mentioned books

Mar 1, 2026 • 13min
Q+A: The Week Ahead | 2 Mar 2026
Stephen Koukoulas, economist and commentator behind The Kook, offers crisp macro forecasts for Australia. He covers expected December-quarter GDP and which components really drive growth. He discusses per-capita GDP and living standards. He weighs the RBA's inflation versus jobs trade-offs. He previews household spending patterns and what building approvals signal for future supply.

Feb 28, 2026 • 14min
Five Questions: Airlines, lounges & 30,000-foot etiquette
Rapid-fire Q&A about airline loyalty, points and whether rewards really shape bookings. A debate on whether loyalty programs are now airlines' core business. Discussion of whether business class is worth splurging or redeeming. Personal best-flight stories, from surprise upgrades to childhood memories. A lively rundown of modern flight pet peeves and 30,000-foot etiquette.

Feb 27, 2026 • 32min
The Saturday Edition | 28 Feb 2026
A lively debate on a surprise inflation print and the pressure it puts on the RBA. A roundup of blockbuster company results and ASX record highs. A heated contest to name the MVP CEO of the last 18 months. Big tech focus with NVIDIA’s historic numbers and the AI hardware boom. Discussion of CGT reform chatter and a proposed Trump-branded Gold Coast tower.

5 snips
Feb 27, 2026 • 6min
Afternoon Report | Earnings season ends, ASX on high
Markets hit a fresh ASX record and sector winners grabbed attention. Political fallout as a major review remains unpublished. Final day of reporting season brought mixed company updates and capital-raise drama. Regulators take action against an insurer over alleged overcharging. A major payments firm announces sweeping job cuts and a costly restructure.

Feb 26, 2026 • 17min
Qantas takes a dive; ASX, global sharemarkets hit records; mobile phones test warning
Qantas posts a record profit but international weakness sends its share price sliding. ASX and global markets reach new highs with tech leading the charge. A nationwide mobile phone test will send a 10-second emergency siren. Capital gains tax changes are under review amid discussions of retrospective rules. Missing FBI pages in the Epstein files spark fresh controversy.

Feb 26, 2026 • 13min
Q+A: How property will change as Domain goes global
Last year Domain became part of Nasdaq-listed CoStar Group, a global leader in commercial real estate data and analytics. Domain President Jason Pellegrino joins Sean Aylmer to explain what that means for the Australian property platform and how being part of a much larger, data-driven international organisation changes the game.They discuss why confidence is the core need of property buyers everywhere, how AI is reshaping the journey, and why commercial property in Australia is a “white space” ripe for disruption.Domain is a supporter of Fear & GreedFind out more: https://fearandgreed.com.au/See omnystudio.com/listener for privacy information.

5 snips
Feb 26, 2026 • 7min
Afternoon Report | ASX hits another record
Markets hit fresh highs with tech leading gains after a blockbuster chipmaker report. Major miners and healthcare stocks made notable moves while airlines and steel firms slipped. Central bank comments on inflation and the labour market shaped policy expectations. Diplomatic families were advised to leave a volatile region as geopolitical tensions rose.

Feb 25, 2026 • 14min
Rate hike likely after CPI surprise; ASX record high; Trump’s rollicking State of the Union
Higher-than-expected CPI lifts the odds of a near-term interest rate hike. The ASX hits a record high amid strong corporate results. Woolworths posts a bumper profit and a one-day share surge. WiseTech announces 2,000 job cuts as AI reshapes work. A lengthy, theatrical State of the Union fuels talk of tariffs, courts and foreign policy.

Feb 25, 2026 • 12min
Q+A: How this biotech CEO keeps the faith in a cancer cure
Leslie Chong, CEO and Managing Director of Imugene with decades in cancer drug development. She discusses why she stays committed to long biotech timelines. She names azur‑cel as the lead CAR‑T prospect and explains its off‑the‑shelf donor approach. She covers trial stages, FDA feedback, fast‑to‑market niche strategies, and choices between partnering or commercialising alone.

Feb 25, 2026 • 6min
Afternoon Report | ASX hits record
Markets rally sends the ASX 200 to a record close and tech stocks stage a rebound. Woolworths soars after a surprise earnings beat and miners post strong results. A bomb threat prompts a prime ministerial evacuation in Canberra. Deloitte tightens rules on public AI use. The Louvre director steps down after a high-profile jewel theft.


